Global Irritable Bowel Syndrome (IBS) Market 2018 : By Application, Type, Key Players, Region and Forecast to 2022

Sales Report in Graphs and Charts

The Report named global Irritable Bowel Syndrome (IBS) Market serves crucial perceptions into global Irritable Bowel Syndrome (IBS) industry along with newfangled industry details, currently dominating players in Irritable Bowel Syndrome (IBS), Topics wise analysis of each section and looming industry trends, which will guide the readers to target Irritable Bowel Syndrome (IBS) market product Specifications and clients driving the long-term market revenue and profitability.

This report studies the Irritable Bowel Syndrome market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Irritable Bowel Syndrome market by product type and applications/end industries.

The major players in global Irritable Bowel Syndrome market include
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience

Geographically, this report is segmented into several key Regions, with revenue, market share and growth rate of Irritable Bowel Syndrome in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Japan
RoW

On the basis of product, the Irritable Bowel Syndrome market is primarily split into
IBS-D Drug
IBS-C Drug
Other

On the basis on the end users/applications, this report covers
Women
Men

Table of Contents

1 Irritable Bowel Syndrome Market Overview 1
1.1 Product Overview and Scope of Irritable Bowel Syndrome 1
1.2 Irritable Bowel Syndrome Segment by Types (Product Category) 2
1.2.1 Global Irritable Bowel Syndrome Revenue and Growth Rate (%) Comparison by Types (Product Category) (2016-2022) 2
1.2.2 Global Irritable Bowel Syndrome Market Share (%) by Types (Product Category) in 2016 3
1.2.3 IBS-D Drug 4
1.2.4 IBS-C Drug 4
1.2.5 Other 5
1.3 Global Irritable Bowel Syndrome Segment by Applications 5
1.3.1 Global Irritable Bowel Syndrome Sales Comparison by Applications (2012-2022) 5
1.3.2 Women 7
1.3.3 Men 7
1.4 Global Irritable Bowel Syndrome Market by Regions (2012-2022) 8
1.4.1 Global Irritable Bowel Syndrome Market Size (M USD) Comparison by Regions (2012-2022) 8
1.4.2 North America Irritable Bowel Syndrome Status and Prospect (2012-2022) 9
1.4.3 Japan Irritable Bowel Syndrome Status and Prospect (2012-2022) 10
1.4.4 Europe Irritable Bowel Syndrome Status and Prospect (2012-2022) 11
1.4.5 RoW Irritable Bowel Syndrome Status and Prospect (2012-2022) 12
1.5 Global Irritable Bowel Syndrome Market Size (2012-2022) 13
2 Global Irritable Bowel Syndrome Market Competition by Manufacturers 14
2.1 Global Irritable Bowel Syndrome Revenue and Market Share by Manufacturers (2016-2017) 14
2.2 Global Irritable Bowel Syndrome Gross Margin by Manufacturers (2016-2017) 16
2.3 Manufacturers Irritable Bowel Syndrome Headquarter, Sales Area, Product Types 17
2.4 Irritable Bowel Syndrome Market Competitive Situation and Trends 19
2.4.1 Irritable Bowel Syndrome Market Concentration Rate 19
2.4.2 Irritable Bowel Syndrome Revenue Market Share (%) of Top 3 and Top 5 Manufacturers in 2016 20
2.4.3 Mergers & Acquisitions, Expansion 21
3 Global Irritable Bowel Syndrome Revenue by Regions (2012-2017) 23
3.1 Global Irritable Bowel Syndrome Revenue and Market Share (%) by Regions (2012-2017) 23
3.2 Global Irritable Bowel Syndrome Revenue and Gross Margin (%) (2012-2017) 26
3.3 North America Irritable Bowel Syndrome Revenue and Gross Margin (%) (2012-2017) 27
3.4 Europe Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017) 27
3.5 Japan Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017) 27
3.6 RoW Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017) 28
4 Global Irritable Bowel Syndrome Revenue Size by Types 29
4.1 Global Irritable Bowel Syndrome Revenue and Market Share by Types (2012-2017) 29
4.2 Global Irritable Bowel Syndrome Growth by Type (2012-2017) 31
5 Global Irritable Bowel Syndrome Market Analysis by Applications 32
5.1 Global Irritable Bowel Syndrome Sales and Market Share by Applications (2012-2017) 32
5.2 Global Irritable Bowel Syndrome Sales Growth Rate by Applications (2012-2017) 34
6 Global Irritable Bowel Syndrome Manufacturers Profiles/Analysis 35
6.1 Allergan 35
6.1.1 Company Basic Information, Key Products and Sales Area 35
6.1.2 Irritable Bowel Syndrome Product Category, Application and Specification 36
6.1.3 Allergan Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 37
6.2 Valeant Pharmaceuticals 38
6.2.1 Company Basic Information, Key Products and Sales Area 38
6.2.2 Irritable Bowel Syndrome Product Category, Application and Specification 39
6.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 40
6.3 Takeda 40
6.3.1 Company Basic Information, Key Products and Sales Area 40
6.3.2 Irritable Bowel Syndrome Product Category, Application and Specification 41
6.3.3 Takeda Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 42
6.4 Sucampo Pharmaceuticals 42
6.4.1 Company Basic Information, Key Products and Sales Area 42
6.4.2 Irritable Bowel Syndrome Product Category, Application and Specification 43
6.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 44
6.5 McNeil Consumer Healthcare 45
6.5.1 Company Basic Information, Key Products and Sales Area 45
6.5.2 Irritable Bowel Syndrome Product Category, Application and Specification 46
6.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 46
6.6 Sebela Pharmaceuticals 47
6.6.1 Company Basic Information, Key Products and Sales Area 47
6.6.2 Irritable Bowel Syndrome Product Category, Application and Specification 48
6.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 48
6.7 Astellas Pharmaceuticals 49
6.7.1 Company Basic Information, Key Products and Sales Area 49
6.7.2 Irritable Bowel Syndrome Product Category, Application and Specification 50
6.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 51
6.8 IM HealthScience 51
6.8.1 Company Basic Information, Key Products and Sales Area 51
6.8.2 Irritable Bowel Syndrome Product Category, Application and Specification 52
6.8.3 IM HealthScience Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 53
7 Irritable Bowel Syndrome Manufacturing Cost Analysis 54
7.1 Irritable Bowel Syndrome R&D Cost Analysis 54
7.1.1 Clinical Phase Costs 55
7.1.2 Capitalized Costs 56
7.1.3 United States Irritable Bowel Syndrome Medical Cost 57
7.2 Proportion of Manufacturing Cost Structure 57
7.2.1 Raw Materials 58
7.2.2 Labor Cost 58
7.2.3 Manufacturing Expenses 63
8 Industrial Chain, Sourcing Strategy and Downstream Buyers 69
8.1 Irritable Bowel Syndrome Industrial Chain Analysis 69
8.2 Upstream Raw Materials Sourcing 69
8.3 Downstream Buyers 70
9 Marketing Strategy Analysis, Distributors/Traders 71
9.1 Marketing Channel 71
9.1.1 Direct Marketing 71
9.1.2 Indirect Marketing 71
9.1.3 Marketing Channel Development Trend 71
9.2 Market Positioning 72
9.2.1 Pricing Strategy 72
9.2.2 Brand Strategy 73
9.3 Distributors/Traders List 74
10 Market Effect Factors Analysis 75
10.1 Irritable Bowel Syndrome Facts and Dynamic 75
10.1.1 FDA Approves Two Therapies to Treat IBS-D in 2015 75
10.1.2 Irritable Bowel Syndrome Facts 76
10.2 Consumer Needs/Customer Preference Change 78
10.3 Economic/Political Environmental Change 79
11 Global Irritable Bowel Syndrome Market Forecast (2017-2022) 87
11.1 Global Irritable Bowel Syndrome Sales Revenue (M USD) Forecast (2017-2022) 87
11.2 Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Regions (2017-2022) 87
11.2.1 North America Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022) 89
11.2.2 Europe Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022) 90
11.2.3 Japan Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022) 91
11.2.4 RoW Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022) 92
11.3 Global Irritable Bowel Syndrome Sales Revenue (M USD) Forecast by Type (2017-2022) 92
11.4 Global Irritable Bowel Syndrome Revenue Forecast by Application (2017-2022) 94
12 Research Findings and Conclusion 96
13 Methodology and Data Source 97
13.1 Methodology/Research Approach 97
13.1.1 Research Programs/Design 97
13.1.2 Market Size Estimation 98
13.1.3 Market Breakdown and Data Triangulation 99
13.2 Data Source 100
13.2.1 Secondary Sources 100
13.2.2 Primary Sources 101
13.3 Disclaimer 102
13.4 Author List 103

List of Tables and Figures

Figure Product Picture of Irritable Bowel Syndrome 1
Table Global Irritable Bowel Syndrome Revenue and Growth Rate (%) Comparison by Types (2016-2022) 2
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) by Types (Product Category) in 2016 3
Table Irritable Bowel Syndrome Type and Characteristic 3
Figure Product Picture of IBS-D Drug 4
Figure Product Picture of IBS-C Drug 4
Figure Product Picture of Other 5
Table Global Irritable Bowel Syndrome Sales Comparison by Applications (2012-2022) 5
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications in 2016 6
Table IBS Symptoms in Men and Women 6
Figure Women Examples 7
Figure Men Examples 7
Figure Global Irritable Bowel Syndrome Market Size (M USD) Comparison by Regions (2012-2022) 8
Figure North America Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022) 9
Figure Japan Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022) 10
Figure Europe Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022) 11
Figure RoW Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022) 12
Figure Global Irritable Bowel Syndrome Revenue (M USD) Status and Outlook (2012-2022) 13
Table Global Irritable Bowel Syndrome Revenue (M USD) by Manufacturers (2016-2017) 14
Table Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers (2016-2017) 14
Figure 2016 Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers 15
Figure 2017 Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers 16
Table Global Market Irritable Bowel Syndrome Gross Margin) of Key Manufacturers (2016-2017) 16
Figure Global Market Irritable Bowel Syndrome Gross Margin of Key Manufacturers in 2016 17
Table Manufacturers Irritable Bowel Syndrome Headquarter and Sales Area 17
Table Manufacturers Irritable Bowel Syndrome Product Category 18
Figure Irritable Bowel Syndrome Market Concentration Rate in 2016 19
Figure Irritable Bowel Syndrome Revenue Market Share (%) of Top 3 Manufacturers in 2016 20
Figure Irritable Bowel Syndrome Revenue Market Share (%) of Top 5 Manufacturers in 2016 20
Table Mergers & Acquisitions, Expansion News 21
Table Global Irritable Bowel Syndrome Revenue (M USD) by Regions (2012-2017) 23
Table Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions (2012-2017) 23
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions (2012-2017) 24
Figure 2016 Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions 24
Figure 2017 Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions 25
Figure Global Irritable Bowel Syndrome Revenue and Growth Rate (%) (2012-2017) 26
Table Global Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 26
Table North America Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 27
Table Europe Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 27
Table Japan Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 27
Table RoW Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 28
Table Global Irritable Bowel Syndrome Revenue (M USD) by Types (2012-2017) 29
Table Global Irritable Bowel Syndrome Revenue Share (%) by Types (2012-2017) 29
Figure Revenue Share (%) Irritable Bowel Syndrome by Types (2012-2017) 30
Figure 2016 Revenue Market Share (%) of Irritable Bowel Syndrome by Types 30
Table Global Irritable Bowel Syndrome Growth by Type (2012-2017) 31
Figure Global Irritable Bowel Syndrome Growth by Type (2012-2017) 31
Table Global Irritable Bowel Syndrome Sales by Applications (2012-2017) 32
Table Global Irritable Bowel Syndrome Sales Market Share (%) by Applications (2012-2017) 32
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications (2012-2017) 33
Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications in 2016 33
Table Global Irritable Bowel Syndrome Sales Growth Rate (%) by Applications (2012-2017) 34
Figure Global Irritable Bowel Syndrome Sales Growth Rate (%) by Applications (2012-2017) 34
Table Allergan Basic Information, Key Products and Sales Area 35
Table Irritable Bowel Syndrome Product Category, Application and Specification 36
Table Allergan Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 37
Table Valeant Pharmaceuticals Basic Information, Key Products and Sales Area 38
Table Irritable Bowel Syndrome Product Category, Application and Specification 39
Table Valeant Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 40
Table Takeda Basic Information, Key Products and Sales Area 40
Table Irritable Bowel Syndrome Product Category, Application and Specification 41
Table Takeda Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 42
Table Sucampo Pharmaceuticals Basic Information, Key Products and Sales Area 42
Table Irritable Bowel Syndrome Product Category, Application and Specification 43
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 44
Table McNeil Consumer Healthcare Basic Information, Key Products and Sales Area 45
Table Irritable Bowel Syndrome Product Category, Application and Specification 46
Table McNeil Consumer Healthcare Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 46
Table Sebela Pharmaceuticals Basic Information, Key Products and Sales Area 47
Table Irritable Bowel Syndrome Product Category, Application and Specification 48
Table Sebela Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 48
Table Astellas Pharmaceuticals Basic Information, Key Products and Sales Area 49
Table Irritable Bowel Syndrome Product Category, Application and Specification 50
Table Astellas Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 51
Table IM HealthScience Basic Information, Key Products and Sales Area 51
Table Irritable Bowel Syndrome Product Category, Application and Specification 52
Table IM HealthScience Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 53
Figure Typical Phases from Research to the Market for a Drug Candidate 55
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Irritable Bowel Syndrome Compound 56
Table Capitalized Preclinical and Clinical Period Costs per Investigational Irritable Bowel Syndrome Compound 57
Table Manufacturing Cost Structure of Irritable Bowel Syndrome 57
Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 59
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016 59
Figure 2016 Global Manufacturing Competitiveness Index rankings by country 60
Figure US Nonfarm Unit Labor Cost 2014-2016 61
Figure USA Average Hourly Wages (USD/H) 2016-2017 61
Figure China Labor Cost Index 2014-2016 62
Figure China Average Yearly Wages 2006-2016 62
Figure Euro Area Labor Cost 2014-2016 63
Table Gross Margin of Electricity to Ultimate Customers 2007-2016 63
Figure Electricity Prices for Household Consumers in 2016 65
Figure Summary of the Driving Assumptions 66
Figure Industrial Electric Rates 2016 (PER KWH) 67
Figure Irritable Bowel Syndrome Industrial Chain Analysis 69
Table Major Buyers of Irritable Bowel Syndrome 70
Figure Setting Pricing Policy 72
Table Distributors/Traders List 74
Figure IBS Causes, Changes, Triggers and Symptoms 78
Figure Global GDP Growth Rate for 2016 79
Figure US GDP 2006-2016 (Billion USD) 80
Figure US CPI Change 2016-2017 80
Figure EU GDP 2006-2016 (Billion USD) 81
Figure EU CPI Change 2012-2016 81
Figure Germany GDP 2006-2016 (Billion USD) 82
Figure UK GDP 2006-2016 (Billion USD) 82
Figure UK CPI Change 2016-2017 83
Figure Italy GDP 2006-2016 (Billion USD) 83
Figure Italy CPI Change 2016-2017 84
Figure Japan CPI Change 2012-2016 84
Figure Japan GDP 2006-2016 (Billion USD) 85
Figure China GDP 2006-2016 (Billion USD) 85
Figure China CPI Change 2016-2017 86
Figure Global Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 87
Table Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Regions (2017-2022) 87
Figure Global Irritable Bowel Syndrome Sales Market Share (%) Forecast by Regions (2017-2022) 88
Figure North America Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022) 89
Figure Europe Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022) 90
Figure Japan Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022) 91
Figure RoW Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022) 92
Table Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Type (2017-2022) 92
Table Global Irritable Bowel Syndrome Revenue Share Forecast by Type (2017-2022) 93
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) Forecast by Type (2017-2022) 93
Figure Global Irritable Bowel Syndrome Revenue Market Share (%) Forecast by Type in 2022 94
Table Global Irritable Bowel Syndrome Revenue Forecast by Application (2017-2022) 94
Table Global Irritable Bowel Syndrome Revenue Share Forecast by Application (2017-2022) 94
Figure Global Irritable Bowel Syndrome Sales Forecast by Application (2017-2022) 95
Figure Global Irritable Bowel Syndrome Sales Forecast by Application in 2022 95



Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:





Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:




Sharing is caring!

About the Author

Sagar
Sagar Kanherker is a Research Analyst at qymarkets.biz more than 3 years. Due to his in-depth knowledge and dedication to readers, his work has been featured in top publications. Combined, His high-level education from one of the country’s most reputable university and expertise in technology allows him to write unique and impelling news stories.

Be the first to comment on "Global Irritable Bowel Syndrome (IBS) Market 2018 : By Application, Type, Key Players, Region and Forecast to 2022"

Leave a comment

Your email address will not be published.


*